BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.29M | -19.31M | -6.58M | 19.35M | 25.41M |
| Total Depreciation and Amortization | 1.55M | 895.20K | 381.00K | 348.20K | 296.10K |
| Total Amortization of Deferred Charges | 0.00 | 25.40K | 63.60K | 101.80K | 140.00K |
| Total Other Non-Cash Items | 20.22M | 19.65M | 20.06M | 4.39M | 3.96M |
| Change in Net Operating Assets | 600.80K | 3.78M | -3.98M | -8.92M | -2.74M |
| Cash from Operations | -5.92M | 5.04M | 9.94M | 15.26M | 27.06M |
| Capital Expenditure | -2.91M | -3.19M | -3.35M | -3.05M | -748.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -15.02M | -15.02M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.25M | 1.25M | 1.25M | 1.25M | -1.25M |
| Cash from Investing | -16.68M | -16.96M | -2.10M | -1.80M | -2.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.65M | -1.07M | -1.17M | -1.26M | -1.22M |
| Issuance of Common Stock | 2.52M | 15.00K | 48.30K | 340.90K | 425.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -146.30K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -1.28M | -1.05M | -1.12M | -920.30K | -790.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -23.88M | -12.97M | 6.72M | 12.54M | 24.27M |